Navigating the landscape of personalized oncology: overcoming challenges and expanding horizons with computational modeling
Journal of the American Medical Informatics Association · 2026
DOI: 10.1093/jamia/ocaf144 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Medical Informatics Association, 2026. Verfasst von Melike Sirlanci und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Informatics, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, United States. Hauptthemen laut MEDLINE: Precision Medicine, Machine Learning, Medical Oncology, Lymphoma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Objectives
We discuss challenges using computational modeling approaches for personalized prediction in clinical practice to predict treatment response for rare diseases treated by novel therapies using clinical oncology as an example context. Several challenges are discussed, including data scarcity, data sparsity, and difficulties in establishing interdisciplinary teams. Machine learning (ML), mechanistic modeling (MM), and hybrid modeling (HM) are discussed in the context of these challenges. Materials and Methods We present an HM approach, combining ML and MM techniques for improved personalized model estimation in the context of chimeric antigen receptor T-cell therapy for aggressive lymphoma.
Results
The HM approach improved the root mean squared error by 61.27±23.21% compared to using MM alone (MM: 2.36*105∓1.68*105and HM: 9.57*104∓8.37*104, where the units are in cells), computed from 13 patients included in this study.
Discussion
By exploiting the complementary strengths of ML and MM approaches, the developed HM method addresses common limitations such as data scarcity and sparsity in medical settings, especially common for rare diseases.
Conclusion
The HM techniques are likely required to overcome data scarcity and sparsity issues in broad medical settings. Developing these techniques requires dedicated interdisciplinary teams.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biomedical Informatics, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, United States.
- Department of Applied Mathematics, University of Colorado Boulder, Boulder, CO 80309, United States.
- Department of Biomedical Informatics, Columbia University, New York, NY 10032, United States.
- Department of Bioengineering, University of Colorado Denver, Aurora, CO 80045, United States.
- Department of Biostatistics & Informatics, Colorado School of Public Health, Aurora, CO 80045, United States.
- Department of Radiology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, United States.
ORCID-Profile: Melike Sirlanci, David Albers, Tellen D Bennett
Förderung
- NCI NIH HHS
Zitieren
APA
Sirlanci, M., Albers, D., Kwak, J., Smith, C., Bennett, T. D., & Bair, S. M. (2026). Navigating the landscape of personalized oncology: overcoming challenges and expanding horizons with computational modeling. Journal of the American Medical Informatics Association. https://doi.org/10.1093/jamia/ocaf144
Vancouver
Sirlanci M, Albers D, Kwak J, Smith C, Bennett TD, Bair SM. Navigating the landscape of personalized oncology: overcoming challenges and expanding horizons with computational modeling. Journal of the American Medical Informatics Association. 2026. doi:10.1093/jamia/ocaf144
BibTeX
@article{Sirlanci2026,
author = {Sirlanci, Melike and Albers, David and Kwak, Jennifer and Smith, Clayton and Bennett, Tellen D and Bair, Steven M},
title = {Navigating the landscape of personalized oncology: overcoming challenges and expanding horizons with computational modeling},
journal = {Journal of the American Medical Informatics Association},
year = {2026},
doi = {10.1093/jamia/ocaf144}
}
EUVIMED